Loading…
Pharma Store (ფარმა სთორი, pharmastore.ge) — a Tbilisi-based specialty supplier for aesthetic medicine, importing and distributing dermocosmetics, injectables and related products to clinics and practitioners (24 Chavchavadze Ave., ~20–49 staff). Healthy specialty margins (~50%); active and growing (revenue ~GEL 2.2m in 2021 to ~GEL 6.3m in 2024).
| Ratio | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | 48.8% | 48.2% | 51.4% | 45.8% |
| EBITDA Margin | 30.5% | 21.2% | 12.7% | 16.1% |
| EBITDAR | 683 | 842 | 704 | 1,025 |
| EBITDAR Margin | 31.0% | 21.5% | 12.9% | 16.3% |
| EBIT Margin | 30.3% | 21.1% | 12.5% | 15.7% |
| Net Profit Margin | 29.7% | 20.8% | 9.5% | 13.0% |
| Operating Expense % of Sales | 18.3% | 27.0% | 38.8% | 29.7% |
| Returns | ||||
| Return on Assets (ROA) | 53.2% | 36.7% | 11.6% | 13.7% |
| Return on Equity (ROE) | 63.6% | 44.2% | 21.9% | 25.7% |
| ROIC [EBIT / Invested Capital] | 66.3% | 44.7% | 19.0% | 20.1% |
| Leverage & debt balances | ||||
| Debt-to-Assets | 8.0% | 7.0% | 35.6% | 35.6% |
| Debt-to-Equity | 0.10x | 0.08x | 0.67x | 0.67x |
| Debt-to-EBITDA | 0.15x | 0.19x | 2.28x | 2.09x |
| Equity-to-Assets | 83.7% | 83.0% | 53.1% | 53.4% |
| Net Debt | -20 | 8 | 1,219 | 1,736 |
| Cash & Equivalents | 118 | 147 | 359 | 377 |
| Total Debt | 98 | 155 | 1,578 | 2,113 |
| Liquidity & working capital | ||||
| Current Ratio | 6.01x | 5.72x | 2.70x | 6.84x |
| Quick Ratio | 6.01x | 5.72x | 2.70x | 6.84x |
| Cash Ratio | 0.59x | 0.39x | 0.28x | 0.54x |
| Total Current Assets | 1,204 | 2,155 | 3,497 | 4,783 |
| Total Current Liabilities | 200 | 377 | 1,297 | 700 |
| Inventory | N/A | N/A | N/A | N/A |
| Trade Receivables | 442 | 897 | 1,296 | 1,880 |
| Trade Payables | 49 | 63 | 198 | 376 |
| Net Working Capital | 1,003 | 1,778 | 2,200 | 4,084 |
| Net Working Capital % of Revenue | 45.6% | 45.4% | 40.4% | 65.1% |
| Trade Working Capital | 392 | 834 | 1,098 | 1,503 |
| Trade Working Capital % of Revenue | 17.8% | 21.3% | 20.2% | 24.0% |
| Change in Trade Working Capital | N/A | 442 | 265 | 405 |
| Turnover & efficiency | ||||
| Inventory Turnover | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A |
| Receivables Turnover | 4.98x | 4.37x | 4.20x | 3.34x |
| Days Sales Outstanding (DSO) | 73.2 | 83.5 | 86.8 | 109.4 |
| Payables Turnover | 22.80x | 32.31x | 13.37x | 9.03x |
| Days Payable Outstanding (DPO) | 16.0 | 11.3 | 27.3 | 40.4 |
| Cash Conversion Cycle | 57.2 days | 72.2 days | 59.5 days | 68.9 days |
| Asset Turnover | 1.79x | 1.77x | 1.23x | 1.06x |
| Cash flow & dividends | ||||
| Operating Cash Flow | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →